(Q35683211)

9 August 2017

1 reference

title

Pregnancy exposure registries (English)

1 reference

9 August 2017

Dianne L Kennedy

1

1 reference

9 August 2017

Kathleen Uhl

series ordinal

2

1 reference

9 August 2017

Sandra L Kweder

series ordinal

3

1 reference

9 August 2017

publication date

1 January 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

27

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

215-228

1 reference

Guideline for the study and evaluation of gender differences in the clinical evaluation of drugs; notice.

9 August 2017

cites work

1 reference

12 December 2020

A North American Registry for Epilepsy and Pregnancy, a unique public/private partnership of health surveillance

1 reference

12 December 2020

Therapeutic drug use during pregnancy: a comparison in four European countries. OECM Working Group. Occupational Exposures and Congenital Anomalies.

1 reference

12 December 2020

Postmarketing surveillance for human teratogenicity: a model approach.

1 reference

12 December 2020

Systematic Identification of Drugs That Cause Birth Defects — A New Opportunity

1 reference

12 December 2020

Trends in pregnancies and pregnancy rates by outcome: estimates for the United States, 1976-96

1 reference

12 December 2020

The interaction between dysmorphology and epidemiology: methodologic issues of lumping and splitting

1 reference

12 December 2020

The Organization of Teratology Information Services (OTIS) Registry Study

1 reference

12 December 2020

Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey

1 reference

12 December 2020

A prospective study of early pregnancy loss

1 reference

12 December 2020

Predictive value of minor anomalies. I. Association with major malformations

1 reference

12 December 2020

Congenital Malformations Surveillance: Two American Systems

1 reference

12 December 2020

Prescription of drugs during pregnancy in France

1 reference

12 December 2020

Determination of pregnancy outcome risk rates after exposure to an intervention

1 reference

12 December 2020

Guidelines for Good Epidemiology Practices for drug, device, and vaccine research in the United States

1 reference

12 December 2020

Need for inclusion and exclusion criteria for the structural abnormalities recorded in children born from exposed pregnancies

1 reference

12 December 2020

Varicella vaccine exposure during pregnancy: data from the first 5 years of the pregnancy registry

1 reference

12 December 2020

Birth outcomes following zidovudine exposure in pregnant women: the Antiretroviral Pregnancy Registry

1 reference

12 December 2020

Difficulties in the study of adverse fetal and neonatal effects of drug therapy during pregnancy

1 reference

12 December 2020

The American College of Allergy, Asthma, and Immunology Registry for Allergic, Asthmatic Pregnant Patients (RAAPP).

1 reference

12 December 2020

Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment

1 reference

12 December 2020

Birth defect classification by organ system: a novel approach to heighten teratogenic signalling in a pregnancy registry.

1 reference

12 December 2020

Evaluation of selected characteristics of pregnancy drug registries

1 reference

12 December 2020

10.2165/00002018-200427040-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

9 August 2017

1040543281

0 references

1 reference